Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
Lucid Diagnostics獲得納斯達克延長180天以恢復符合最低買盤價格規則的合規性
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
Lucid Diagnostics獲得納斯達克延長180天以恢復符合最低買盤價格規則的合規性
譯文內容由第三人軟體翻譯。